Drug Authority recalls antihistamine tablets
In 2026, the Drug Authority issued a withdrawal and warning notice regarding Mepahist Tablets, to monitor their quality and safety in the Egyptian market. This medication is used as an anti-allergy agent and helps alleviate various allergy symptoms.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)